ClinVar Miner

Submissions for variant NM_001943.5(DSG2):c.1605C>A (p.Asp535Glu)

dbSNP: rs368718022
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000485939 SCV000570979 uncertain significance not provided 2016-07-15 criteria provided, single submitter clinical testing A variant of uncertain significance has been identified in the DSG2 gene. The D535E variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The D535E variant was not observed with any significant frequency in approximately 6,000 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project. This substitution occurs at a position that is conserved across species. However, the D535E variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. Finally, in silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or rare benign.
Invitae RCV000821976 SCV000962752 uncertain significance Arrhythmogenic right ventricular dysplasia 10 2021-08-27 criteria provided, single submitter clinical testing This sequence change replaces aspartic acid with glutamic acid at codon 535 of the DSG2 protein (p.Asp535Glu). The aspartic acid residue is highly conserved and there is a small physicochemical difference between aspartic acid and glutamic acid. This variant is present in population databases (rs368718022, ExAC 0.002%). This variant has not been reported in the literature in individuals affected with DSG2-related conditions. ClinVar contains an entry for this variant (Variation ID: 421691). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV002402407 SCV002706418 uncertain significance Cardiovascular phenotype 2022-06-14 criteria provided, single submitter clinical testing The p.D535E variant (also known as c.1605C>A), located in coding exon 11 of the DSG2 gene, results from a C to A substitution at nucleotide position 1605. The aspartic acid at codon 535 is replaced by glutamic acid, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Fulgent Genetics, Fulgent Genetics RCV002506171 SCV002816743 uncertain significance Arrhythmogenic right ventricular dysplasia 10; Dilated cardiomyopathy 1BB 2021-09-15 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV003532142 SCV004363194 uncertain significance Cardiomyopathy 2022-11-06 criteria provided, single submitter clinical testing This missense variant replaces aspartic acid with glutamic acid at codon 535 of the DSG2 protein. Computational prediction suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold <= 0.5, PMID: 27666373). To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with DSG2-related disorders in the literature. This variant has been identified in 1/249308 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.